Unger-Vetlesen Institute, Lovisenberg Diaconal Hospital, Oslo, Norway.
Department of Clinical Support, Lovisenberg Diaconal Hospital, Oslo, Norway.
Scand J Gastroenterol. 2024 Oct;59(10):1166-1171. doi: 10.1080/00365521.2024.2395848. Epub 2024 Sep 4.
Gastrointestinal illnesses have been reported in relation to low disaccharidase activity, yet both the prevalence of disaccharidase deficiency and its association with gastrointestinal symptoms and irritable bowel syndrome (IBS) are largely unknown. We aimed to determine the association between low activity of disaccharidase enzymes on gastrointestinal symptoms and presence of IBS.
Patients referred for gastroscopic examination due to gastrointestinal complaints were consecutively included. A pinch biopsy was taken from the distal part of duodenum, and disaccharidase activity was measured using the Dahlqvist method. Gastrointestinal symptom severity was measured using IBS-Symptom Severity Score (IBS-SSS).
A total of 40 patients were included. Disaccharidase deficiency was detected in 24 patients (60%). Half of the patients ( = 21) had IBS according to Rome IV criteria. A majority (75%) of all patients reported moderate to severe gastrointestinal symptoms. Moderate to severe gastrointestinal symptoms were reported by 16 patients (67%) with disaccharidase deficiency and in 14 patients (88%) with normal disaccharidase activity. Lactase deficiency was detected in 22 patients (55%), maltase deficiency in 11 patients (28%), sucrase deficiency in 9 patients (23%), isomaltase deficiency in 13 patients (33%) and glucoamylase deficiency in 12 patients (30%). The activity of all enzymes was reduced in 8 patients (20%). Degree of disaccharidase deficiency was not associated with either the severity of gastrointestinal symptoms or the diagnosis of IBS. Enzymes levels were not associated with gastrointestinal symptom scores.
Our findings did not reveal any association between biochemically measured disaccharidase deficiency and gastrointestinal symptoms or the presence of IBS.
已有报道称,胃肠道疾病与低双糖酶活性有关,但双糖酶缺乏的患病率及其与胃肠道症状和肠易激综合征(IBS)的关系在很大程度上尚不清楚。我们旨在确定双糖酶活性降低与胃肠道症状和 IBS 之间的关系。
连续纳入因胃肠道症状而接受胃镜检查的患者。从十二指肠远端取一小部分活检组织,使用 Dahlqvist 法测量双糖酶活性。使用 IBS 症状严重程度评分(IBS-SSS)测量胃肠道症状严重程度。
共纳入 40 例患者。24 例(60%)患者存在双糖酶缺乏。根据 Rome IV 标准,有一半(21 例)患者患有 IBS。大多数(75%)患者报告有中度至重度胃肠道症状。24 例(67%)双糖酶缺乏症患者和 14 例(88%)双糖酶正常患者报告有中度至重度胃肠道症状。22 例(55%)患者存在乳糖酶缺乏,11 例(28%)患者存在麦芽糖酶缺乏,9 例(23%)患者存在蔗糖酶缺乏,13 例(33%)患者存在异麦芽糖酶缺乏,12 例(30%)患者存在葡萄糖淀粉酶缺乏。8 例(20%)患者所有酶的活性均降低。双糖酶缺乏的严重程度与胃肠道症状的严重程度或 IBS 的诊断均无相关性。酶水平与胃肠道症状评分无关。
我们的研究结果并未发现生化检测的双糖酶缺乏与胃肠道症状或 IBS 的存在之间存在任何关联。